Industry Insight
Discovery Technology
Analytical Laboratory Technology
Biopharma
Manufacturing
Delivery Systems
Ingredients, Formulation and Finishing
Bioprocessing
View our other publications with free access to extensive archives
  To print this article:
Existing subscribers please log in:
 
  USER NAME  
  PASSWORD  
   Or select

Or become a subscriber
 
 
 

Novel Glycosylation Technologies for the Development of Biosimilars and Biobetters

Glycosylation has moved centre-stage in the development of biopharmaceutical products and, in the near future, it can be expected that the therapeutic and commercial success of many products will depend on correct glycosylation patterns.

By Hans Baumeister and Steffen Goletz at Glycotope (December 2009)

Keywords: glycosylation, biosimilars, biobetters, therapeutic, baumeister, goletz, glycotope

    View full article    |    Back to Bioprocessing section




Advair,Flovent,VentolinSymbicort,Serevent,FlonaseAstelin Rhinocort
IPTonline © 2004 The Pharmaceutical Technology Journal | Terms and Conditions | info@iptonline.com | UK Contacts |
Providing a platform of communication on new ideas, developments and innovations | UK Tel No. +44 20 77243456 | Back to top of page |